# EDGAR Filing Document

**Accession Number:** 0001228922
**File Stem:** 0001437749-25-029589
**Filing Date:** 2025-9
**Character Count:** 28691
**Document Hash:** 62cef7daf549f652d3a7c3beacb6b1e0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-029589.hdr.sgml**: 20250922

**ACCESSION NUMBER**: 0001437749-25-029589

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20250922

**DATE AS OF CHANGE**: 20250922

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HIGHLAND OPPORTUNITIES & INCOME FUND
- **CENTRAL INDEX KEY:** 0001710680

**ORGANIZATION NAME:**
- **EIN:** 456245636
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-90216
- **FILM NUMBER:** 251330161

**BUSINESS ADDRESS:**
- **STREET 1:** 300 CRESCENT COURT
- **STREET 2:** SUITE 700
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75201
- **BUSINESS PHONE:** 214-276-6300

**MAIL ADDRESS:**
- **STREET 1:** 300 CRESCENT COURT
- **STREET 2:** SUITE 700
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75201

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HIGHLAND INCOME FUND\MA
- **DATE OF NAME CHANGE:** 20190521

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HIGHLAND FLOATING RATE OPPORTUNITIES FUND
- **DATE OF NAME CHANGE:** 20170925

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HIGHLAND FLOATING RATE OPPORTUNITIES FUND II
- **DATE OF NAME CHANGE:** 20170628
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DONDERO JAMES D
- **CENTRAL INDEX KEY:** 0001228922

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **STREET 1:** 300 CRESCENT COURT
- **STREET 2:** SUITE 700
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75201

## Ex-99

**Exhibit 99.1** 

**JOINT FILING AGREEMENT** 

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the common shares of Highland Opportunities and Income Fund, and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filings.

The undersigned further agree that each party hereto is responsible for the timely filing of such Statement on Schedule 13D and any amendments thereto, and for the accuracy and completeness of the information concerning such party contained therein; provided, however, that no party is responsible for the accuracy or completeness of the information concerning any other party, unless such party knows or has reason to believe that such information is inaccurate.

This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of September 22, 2025.

---

| |
|:---|
| /s/ James D. Dondero |
| James D. Dondero |
| DRUGCRAFTERS, L.P. |
| By: Pharmacy Ventures II, LLC |
| <u>/s/ James D. Dondero</u> |
| Name: James D. Dondero |
| Title: Managing Member of the General Partner |
| HIGHLAND GLOBAL ALLOCATION FUND |
| By: <u>/s/ Stephanie Vitiello</u> |
| Name: Stephanie Vitiello |
| Title: Chief Compliance Officer |
| NEXPOINT ASSET MANAGEMENT, L.P. |
| By: Strand Advisors XVI, Inc., its general partner |
| /s/ James D. Dondero |
| Name: James D. Dondero |
| Title: President |
| /s/ Nancy Marie Dondero |
| Nancy Marie Dondero |

---

## Ex-99

**Exhibit 99.2**

**<u>ANNEX A</u>**

**TRANSACTIONS**

The following table sets forth all transactions with respect to the Common Shares effected in the last 60 days by the Reporting Persons or on behalf of the Reporting Persons in respect of the Common Shares, inclusive of any transactions effected through 4:00 p.m., New York City time, on September 15, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Date** | **Effected By** | **Nature of Transaction** | **Quantity** | **Price** |
| 8/6/2025 | Nancy Marie Dondero (1) | Open Market Purchase | 99394 | $5.80 |
| 8/7/2025 | Nancy Marie Dondero (1) | Open Market Purchase | 57606 | $5.78 |
| 8/8/2025 | Nancy Marie Dondero (1) | Open Market Purchase | 90000 | $5.93 |
| 8/11/2025 | Nancy Marie Dondero (1) | Open Market Purchase | 113423 | $5.99 |
| 8/12/2025 | Nancy Marie Dondero (1) | Open Market Purchase | 45574 | $6.00 |
| 8/13/2025 | Nancy Marie Dondero (1) | Open Market Purchase | 61201 | $6.03 |
| 8/14/2025 | Nancy Marie Dondero (1) | Open Market Purchase | 60351 | $6.02 |
| 8/15/2025 | Nancy Marie Dondero (1) | Open Market Purchase | 67281 | $6.01 |
| 8/18/2025 | Nancy Marie Dondero (1) | Open Market Purchase | 105571 | $5.99 |
| 8/19/2025 | Nancy Marie Dondero (1) | Open Market Purchase | 35702 | $6.01 |
| 8/20/2025 | Nancy Marie Dondero (1) | Open Market Purchase | 37957 | $6.08 |
| 8/21/2025 | Nancy Marie Dondero (1) | Open Market Purchase | 62067 | $6.10 |
| 8/22/2025 | Nancy Marie Dondero (1) | Open Market Purchase | 18967 | $6.12 |
| 8/25/2025 | Nancy Marie Dondero (1) | Open Market Purchase | 31236 | $6.12 |
| 8/26/2025 | Nancy Marie Dondero (1) | Open Market Purchase | 13670 | $6.14 |
| 8/27/2025 | GAF | Open Market Purchase | 11407 | $6.12 |
| 8/28/2025 | GAF | Open Market Purchase | 62912 | $6.14 |
| 9/2/2025 | GAF | Open Market Purchase | 11259 | $6.14 |
| 9/3/2025 | GAF | Open Market Purchase | 20289 | $6.16 |
| 9/4/2025 | GAF | Open Market Purchase | 30694 | $6.49 |
| 9/5/2025 | GAF | Open Market Purchase | 34875 | $6.19 |
| 9/8/2025 | GAF | Open Market Purchase | 44785 | $6.19 |
| 9/9/2025 | GAF | Open Market Purchase | 33205 | $6.13 |
| 9/10/2025 | GAF | Open Market Purchase | 17574 | $6.23 |
| 9/11/2025 | GAF | Open Market Purchase | 38198 | $6.34 |
| 9/12/2025 | GAF | Open Market Purchase | 35924 | $6.44 |
| 9/15/2025 | GAF | Open Market Purchase | 131067 | $6.51 |

---

(1) The transaction reported herein was effected by an entity that is wholly owned by the trust referred to in Item 5(a), for which Ms. Dondero serves as trustee.

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**HIGHLAND OPPORTUNITIES & INCOME FUND**

*(Name of Issuer)*

**Common Shares, par value $0.001 per share**

*(Title of Class of Securities)*

**43010E404**

*(CUSIP Number)*

**Stephanie Vitiello, CCO**<br>NexPoint Asset Management, L.P.<br>300 Crescent Court, Suite 700<br>Dallas TX 75201<br>214-453-6500

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**09/15/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **43010E404** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**DONDERO JAMES D** | Name of reporting person<br>**DONDERO JAMES D** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**1743.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**2875803.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**1743.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**2875803.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**2877547.00** | Aggregate amount beneficially owned by each reporting person<br>**2877547.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**5.2%** | Percent of class represented by amount in Row (11)<br>**5.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **43010E404** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**HIGHLAND GLOBAL ALLOCATION FUND** | Name of reporting person<br>**HIGHLAND GLOBAL ALLOCATION FUND** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**MASSACHUSETTS** | Citizenship or place of organization<br>**MASSACHUSETTS** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**806194.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**806194.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**806194.00** | Aggregate amount beneficially owned by each reporting person<br>**806194.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**1.5%** | Percent of class represented by amount in Row (11)<br>**1.5%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IV** | Type of Reporting Person (See Instructions)<br>**IV** | |

---

| **CUSIP No.** | **43010E404** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Drugcrafters, L.P.** | Name of reporting person<br>**Drugcrafters, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**72082.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**72082.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**72082.00** | Aggregate amount beneficially owned by each reporting person<br>**72082.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.1%** | Percent of class represented by amount in Row (11)<br>**0.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **43010E404** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**NEXPOINT ASSET MANAGEMENT, L.P.** | Name of reporting person<br>**NEXPOINT ASSET MANAGEMENT, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**806194.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**806194.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**806194.00** | Aggregate amount beneficially owned by each reporting person<br>**806194.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**1.5%** | Percent of class represented by amount in Row (11)<br>**1.5%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **43010E404** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**DONDERO NANCY MARIE** | Name of reporting person<br>**DONDERO NANCY MARIE** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1997527.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1997527.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1997527.00** | Aggregate amount beneficially owned by each reporting person<br>**1997527.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**3.6%** | Percent of class represented by amount in Row (11)<br>**3.6%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Shares, par value $0.001 per share

**(b) Name of Issuer:**
HIGHLAND OPPORTUNITIES & INCOME FUND

**(c) Address of Issuer's Principal Executive Offices:**
300 CRESCENT COURT, SUITE 700, DALLAS, TX, 75201

**Item 4. Purpose of Transaction**

Between August 6, 2025 and September 15, 2025, the Reporting Persons purchased 1,372,189 Common Shares in open market transactions with the Reporting Persons' working capital or the working capital of affiliated funds, as applicable, with an aggregate purchase price of $8,361,900. The Reporting Persons acquired such shares for investment purposes. The Reporting Persons intend to purchase additional shares of Common Shares on the open market. However, the timing and amount of such purchases will depend upon a variety of factors, including, without limitation, current and anticipated future trading prices, the financial condition, results of operations and prospects of the Issuer, alternative investment opportunities, general economic, financial market and industry conditions and other factors that the Reporting Persons may deem material to their investment decision. Notwithstanding the foregoing, the Reporting Persons may decide not to make additional purchases or may seek to sell shares of Common Shares depending on general economic and/or market conditions.

Also, consistent with the investment purpose and with NexPoint's role as the investment adviser and fund administrator of the Issuer, the Reporting Persons have, from time to time, engaged in, and expect to continue to engage in, discussions with members of the board of trustees of the issuer, other current or prospective shareholders, industry analysts, existing or potential strategic partners or competitors, investment and financing professionals, sources of credit and other third parties regarding a variety of matters relating to the Issuer, which may include, among other things, the Issuer's business, management, capital structure and allocation, corporate governance, board composition and strategic alternative and direction, and may take other steps seeking to increase shareholder value as well as pursue other plans or proposals that relate to or could result in any of the matters set forth in paragraphs (a) through (j), inclusive, of the instructions to Item 4 of the Schedule 13D. The Reporting Persons intend to review their investment in the Issuer on a continuing basis and may change their intention with respect to any and all matters referred to in paragraphs (a) through (j), inclusive, of the instructions to Item 4 of the Schedule 13D.

Except to the extent the foregoing may be deemed a plan or proposal, the Reporting Persons have no plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) through (j), inclusive, of the instructions to Item 4 of the Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
As of September 15, 2025, (i) James D. Dondero may be deemed to beneficially own 2,877,547.37 Common Shares, which represents approximately 5.2% of the outstanding Common Shares, (ii) Drugcrafters may be deemed to beneficially own 72,082 Common Shares, which represents approximately 0.1% of the outstanding Common Shares, (iii) GAF may be deemed to beneficially own 806,194 shares of Common Shares, which represents approximately 1.5% of the outstanding Common Shares, (iv) NexPoint may be deemed to beneficially own 806,194 shares of Common Shares, which represents approximately 1.5% of the outstanding Common Shares and (v) Nancy Marie Dondero, in her capacity as trustee of a trust, may be deemed to beneficially own 1,997,527.92 shares of Common Shares, which represents approximately 3.6% of the outstanding Common Shares. James D. Dondero has the right to acquire beneficial ownership of all shares of Common Shares owned by the trust referred to in the preceding sentence.

**(b)**
(1)	Mr. Dondero has sole voting power and sole dispositive power with respect to 1,743.45 Common Shares and shared voting power and shared dispositive power with respect to 2,875,803.92 Common Shares. These shares are held by Mr. Dondero indirectly through NexPoint and their advised accounts (as described in paragraph (4) below), Drugcrafters, a proprietary account and a 401(k) account. These also include shares that Mr. Dondero has the right to acquire beneficial ownership of that are held by the trust referred to in Item 5(a), for which he does not serve as trustee.  Mr. Dondero is the sole stockholder and director of NexPoint's general partner, and may be deemed to be an indirect beneficial owner of the shares held by NexPoint. Mr. Dondero disclaims beneficial ownership of such shares.
(2)	Drugcrafters has sole voting power and sole dispositive power with respect to 0 Common Shares and shared voting power and shared dispositive power with respect to 72,082 Common Shares. Mr. Dondero owns 75% of PCMG Trading Partners XXIII, L.P. ("PCMG") and PCMG owns 99% of Drugcrafters. These entities are ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of the shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
(3)	GAF has sole voting power and sole dispositive power with respect to 0 Common Shares and shared voting power and shared dispositive power with respect to 806,194 Common Shares. GAF is managed by NexPoint, which is ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owners of the shares held by GAF. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
(4)	NexPoint has sole voting power and sole dispositive power with respect to 0 Common Shares and shared voting power and shared dispositive power with respect to 806,194 Common Shares. These shares are held by NexPoint indirectly through an advised account. Mr. Dondero is the sole stockholder and director of NexPoint's general partner, and may be deemed to be an indirect beneficial owner of the shares held by NexPoint.
(5)	A trust for which Ms. Dondero serves as trustee has sole voting power and sole dispositive power with respect to 0 Common Shares and shared voting power and shared dispositive power with respect to 1,997,527.92 Common Shares. Ms. Dondero is the sister of Mr. Dondero and disclaims beneficial ownership of such shares.

**(c)**
Annex A attached hereto lists all transactions in Common Shares during the past 60 days by the Reporting Persons. Except as otherwise noted, the transactions in Common Shares were effected in the open market.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

On September 4, 2024, Mr. Dondero and the trust referred to in Item 5(a), for which Ms. Dondero serves as trustee, entered into a loan agreement (the "Loan Agreement") with Lakeside Bank ("Lakeside"), pursuant to which Lakeside made available a credit facility with aggregate advances not to exceed an amount equal to $8.0 million on a revolving basis to Mr. Dondero and the trust referred to in Item 5(a), for which Ms. Dondero serves as trustee (the "Credit Faciliy"), upon the terms and conditions set forth in the Loan Agreement. The Credit Facility has a maturity date of September 6, 2026, at which time all outstanding principal and all accrued and unpaid interest will become due and payable. The proceeds of the Credit Facility are to be used for business and commercial purposes.
In connection with the Credit Facility, the trust referred to in Item 5(a), for which Ms. Dondero serves as trustee, pledged 134,213.93 Common Shares, as collateral for the Credit Facility pursuant to the terms of the Securities Account Control Agreement, dated as of September 6, 2026, by and among Mr. Dondero, the trust referred to in Item 5(a), for which Ms. Dondero serves as trustee, and Lakeside.
On July 1, 2019, Mr. Dondero and the trust referred to in Item 5(a), for which Ms. Dondero serves as trustee, entered into a credit agreement (the "Credit Agreement") with CrossFirst Bank ("CrossFirst"), pursuant to which CrossFirst extended a loan in the principal amount of approximately $13.0 million to Mr. Dondero and the trust referred to in Item 5(a), for which Ms. Dondero serves as trustee (the "Loan"), upon the terms and conditions set forth in the Credit Agreement. The Loan has a maturity date of February 10, 2026, at which time the principal and all accrued and unpaid interest will become due and payable. The proceeds of the Loan are to be used for working capital or other business purposes.

On August 14, 2019, the trust referred to in Item 5(a), for which Ms. Dondero serves as trustee, entered into a revolving line of credit promissory note (the "Note") with CrossFirst, pursuant to which CrossFirst agreed to issue a line of credit, up to an aggregate principal amount of $5.0 million, upon the terms and conditions set forth in the Note. The Note has a maturity date of February 10, 2026, at which time the then outstanding balance of the Note and all accrued but unpaid interest thereon will be due and payable. The proceeds of the Note are to be used for working capital or other business purposes.

In connection with the Loan and the Note, the trust referred to in Item 5(a), for which Ms. Dondero serves as trustee, pledged an aggregate of 376,075.51 shares of the Issuer, as collateral for the Loan and the Note pursuant to the terms of the Pledge Agreement, dated July 1, 2019, by and between the trust referred to in Item 5(a), for which Ms. Dondero serves as trustee, and CrossFirst, and the Pledge Agreement, dated August 14, 2019, by and between the trust referred to in Item 5(a), for which Ms. Dondero serves as trustee, and CrossFirst.

In addition, the trust referred to in Item 5(a), for which Ms. Dondero serves as trustee, holds 3,196.48 Common Shares in, and in the future may hold additional of the Issuer's securities in one or more margin accounts with Morgan Stanley, which provide the trust referred to in Item 5(a), for which Ms. Dondero serves as trustee, with access to margin or other financing. The agreements governing such accounts generally provide the counterparty with security, collateral or similar rights of possession, and sale or offset rights with respect to such account assets in the event of a customer default. Such agreements generally also provide the broker counterparty with rights to lend assets held in such account, in some cases without advance or other notification to the customer.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** DONDERO JAMES D

**Signature:** James D. Dondero

**Name/Title:** James D. Dondero

**Date:** 09/22/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** HIGHLAND GLOBAL ALLOCATION FUND

**Signature:** Stephanie Vitiello

**Name/Title:** Stephanie Vitiello/Chief Compliance Officer

**Date:** 09/22/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Drugcrafters, L.P.

**Signature:** James D. Dondero

**Name/Title:** James D. Dondero/Managing Member of the General Partner

**Date:** 09/22/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** NEXPOINT ASSET MANAGEMENT, L.P.

**Signature:** James D. Dondero

**Name/Title:** James D. Dondero/President

**Date:** 09/22/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** DONDERO NANCY MARIE

**Signature:** Nancy Marie Dondero

**Name/Title:** Nancy Marie Dondero

**Date:** 09/22/2025